## Mechanistic Overview
C1q Binding to Specific Synaptic Proteomes via Neurexin/Neuroligin Complexes starts from the claim that modulating NRXN1, NLGN1 (Neuroligin 1) within the disease context of synaptic biology can redirect a disease-relevant process. The original description reads: "## Mechanistic Overview C1q Binding to Specific Synaptic Proteomes via Neurexin/Neuroligin Complexes starts from the claim that modulating NRXN1, NLGN1 (Neuroligin 1) within the disease context of synaptic biolog
This hypothesis proposes that the CREB-BDNF-TrkB activity-dependent signaling cascade directly controls the spatial positioning and expression levels of complement regulators CD55 and CD46 on synaptic membranes, creating an activity-based tagging system for synaptic elimination. High-frequency neural activity triggers calcium influx and CaMKIV/PKA-mediated CREB1 phosphorylation at serine 133, which transcriptionally upregulates CD55 and CD46 expression while simultaneously promoting their traffi
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
Cell Type Regional VulnerabilityProteostasis Stress Responsesynaptic-biology
Convergent signals
No same-target convergence detected in this selection.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary
2/11
dimensions won
C1q Binding to Specific Synaptic Proteom
11/11
dimensions won
CREB-Dependent Differential Complement R
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.60
0.75
Evidence
0.55
0.72
Novelty
0.68
0.75
Feasibility
0.48
0.70
Impact
0.50
0.80
Druggability
0.35
0.70
Safety
0.50
0.50
Competition
0.75
0.80
Data
0.50
0.55
Reproducible
0.58
0.72
KG Connect
0.50
0.50
Score Breakdown
Dimension
C1q Binding to Specific Synapt
CREB-Dependent Differential Co
Mechanistic
0.600
0.750
Evidence
0.550
0.720
Novelty
0.680
0.750
Feasibility
0.480
0.700
Impact
0.500
0.800
Druggability
0.350
0.700
Safety
0.500
0.500
Competition
0.750
0.800
Data
0.500
0.550
Reproducible
0.580
0.720
KG Connect
0.500
0.500
Evidence
C1q Binding to Specific Synaptic Proteomes via Neurexin/Neur
C1q Binding to Specific Synaptic Proteomes via Neu
4 rounds · quality: 0.75
Persona-Theorist
# Therapeutic Hypotheses: Selectivity of Complement-Mediated Synaptic Elimination During Prolonged Anesthesia
---
## Hypothesis 1: Activity-Dependent Synaptic Tagging via CREB-BDNF TrkB Signaling
*...
Persona-Skeptic
# Critical Evaluation of Hypotheses for Complement-Mediated Synaptic Selectivity
## Overview
These hypotheses address a legitimate gap in understanding how C1q distinguishes between synapses for eli...
Persona-Domain Expert
# Feasibility Assessment: Selectivity Mechanisms in Anesthesia-Induced Synaptic Elimination
## Executive Summary
The central question—whether specific synapses become targets for complement-mediated...
Persona-Synthesizer
{
"ranked_hypotheses": [
{
"title": "Differential Complement Regulator Expression on Synaptic Membranes (CD55/CD46)",
"description": "Excitatory synapses on specific neuronal compart...
CREB-Dependent Differential Complement Regulator P
4 rounds · quality: 0.75
Persona-Theorist
# Therapeutic Hypotheses: Selectivity of Complement-Mediated Synaptic Elimination During Prolonged Anesthesia
---
## Hypothesis 1: Activity-Dependent Synaptic Tagging via CREB-BDNF TrkB Signaling
*...
Persona-Skeptic
# Critical Evaluation of Hypotheses for Complement-Mediated Synaptic Selectivity
## Overview
These hypotheses address a legitimate gap in understanding how C1q distinguishes between synapses for eli...
Persona-Domain Expert
# Feasibility Assessment: Selectivity Mechanisms in Anesthesia-Induced Synaptic Elimination
## Executive Summary
The central question—whether specific synapses become targets for complement-mediated...
Persona-Synthesizer
{
"ranked_hypotheses": [
{
"title": "Differential Complement Regulator Expression on Synaptic Membranes (CD55/CD46)",
"description": "Excitatory synapses on specific neuronal compart...